Endpoints News 25. Feb. 2026 Make way, Camzyos: Cytokinetics touts promising early launch for rival heart drug
Endpoints News 25. Feb. 2026 Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy